August 9, 2007 — BURLINGTON, MA — Hyaluron Contract Manufacturing (HCM), a leader in aseptic formulation and filling, has received preliminary approval of its safety grant application from the Massachusetts Department of Industrial Accidents, Office of Safety. The grant, in the amount of $21,988, will be used to expand HCM’s training program to enhance workplace safety at its Burlington, MA facility.
“Hyaluron has a strong commitment to continued education on safety and the avoidance of injuries to employees,” Shawn Kinney, president of HCM, explains. “With the funds provided through the grant, we will be able to be even more proactive in preventing workplace injuries and promoting the well-being of our employees.”
HCM will use much of the grant to fund newly added courses in Potent Compound Awareness, Respirator Training and Certification, Ergonomic Safety, and First Aid/CPR. All HCM employees receive general safety and emergency training; however, employees in certain areas require more extensive training based on the particular hazards they may encounter. These areas include materials management, engineering, manufacturing, packaging, and quality.
The goal of the training will be to emphasize best practices as well as sound work procedures and decision-making skills. HCM has an active safety committee as well as a zero tolerance policy toward inadequate use of safety equipment and protection materials. Due to stepped-up safety efforts and increased training there were no work-related injuries or illnesses in 2006. The company currently employs eighty people, with plans to add up to twenty more by year end.
Hyaluron Contract Manufacturing (HCM) is a leader in aseptic contract manufacturing of filled liquid parenterals and medical devices. Since 1999, HCM has been offering its customers